Annual CFF
$6.74 M
+$4.74 M+236.82%
31 March 2024
Summary:
Biotricity annual cash flow from financing activities is currently $6.74 million, with the most recent change of +$4.74 million (+236.82%) on 31 March 2024. During the last 3 years, it has fallen by -$5.46 million (-44.76%). BTCY annual CFF is now -73.21% below its all-time high of $25.17 million, reached on 31 March 2022.BTCY Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$471.10 K
-$397.10 K-45.74%
30 September 2024
Summary:
Biotricity quarterly cash flow from financing activities is currently $471.10 thousand, with the most recent change of -$397.10 thousand (-45.74%) on 30 September 2024. Over the past year, it has dropped by -$2.96 million (-86.26%). BTCY quarterly CFF is now -96.82% below its all-time high of $14.81 million, reached on 30 September 2021.BTCY Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$3.32 M
-$2.96 M-47.10%
30 September 2024
Summary:
Biotricity TTM cash flow from financing activities is currently $3.32 million, with the most recent change of -$2.96 million (-47.10%) on 30 September 2024. Over the past year, it has dropped by -$4.54 million (-57.76%). BTCY TTM CFF is now -87.96% below its all-time high of $27.60 million, reached on 31 December 2021.BTCY TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BTCY Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +236.8% | -86.3% | -57.8% |
| 3 y3 years | -44.8% | -96.8% | -85.8% |
| 5 y5 years | +48.0% | -68.0% | -40.4% |
BTCY Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -73.2% | +236.8% | -96.8% | +156.5% | -88.0% | +1985.6% |
| 5 y | 5 years | -73.2% | +236.8% | -96.8% | +156.5% | -88.0% | +1985.6% |
| alltime | all time | -73.2% | >+9999.0% | -96.8% | +156.5% | -88.0% | >+9999.0% |
Biotricity Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $471.10 K(-45.7%) | $3.32 M(-47.1%) |
| June 2024 | - | $868.20 K(-51.5%) | $6.28 M(-6.8%) |
| Mar 2024 | $6.74 M(+236.8%) | $1.79 M(+819.5%) | $6.74 M(-3.0%) |
| Dec 2023 | - | $194.50 K(-94.3%) | $6.95 M(-11.6%) |
| Sept 2023 | - | $3.43 M(+158.0%) | $7.87 M(+88.9%) |
| June 2023 | - | $1.33 M(-33.5%) | $4.16 M(+108.0%) |
| Mar 2023 | $2.00 M(-92.0%) | $2.00 M(+79.9%) | $2.00 M(+1156.5%) |
| Dec 2022 | - | $1.11 M(-506.9%) | $159.30 K(-98.2%) |
| Sept 2022 | - | -$272.80 K(-67.3%) | $8.67 M(-63.5%) |
| June 2022 | - | -$833.20 K(-636.9%) | $23.75 M(-5.6%) |
| Mar 2022 | $25.17 M(+106.2%) | $155.20 K(-98.4%) | $25.17 M(-8.8%) |
| Dec 2021 | - | $9.62 M(-35.1%) | $27.60 M(+17.8%) |
| Sept 2021 | - | $14.81 M(+2449.2%) | $23.42 M(+108.9%) |
| June 2021 | - | $581.10 K(-77.5%) | $11.21 M(-8.1%) |
| Mar 2021 | $12.20 M(+37.4%) | $2.59 M(-52.4%) | $12.20 M(+35.1%) |
| Dec 2020 | - | $5.44 M(+108.9%) | $9.03 M(-11.9%) |
| Sept 2020 | - | $2.60 M(+65.4%) | $10.25 M(+12.4%) |
| June 2020 | - | $1.57 M(-368.8%) | $9.12 M(+2.8%) |
| Mar 2020 | $8.88 M | -$585.50 K(-108.8%) | $8.88 M(-19.2%) |
| Dec 2019 | - | $6.66 M(+351.8%) | $10.99 M(+97.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $1.47 M(+10.9%) | $5.57 M(+4.4%) |
| June 2019 | - | $1.33 M(-12.9%) | $5.34 M(+17.1%) |
| Mar 2019 | $4.56 M(-13.9%) | $1.53 M(+23.4%) | $4.56 M(+50.4%) |
| Dec 2018 | - | $1.24 M(-0.1%) | $3.03 M(-36.1%) |
| Sept 2018 | - | $1.24 M(+125.1%) | $4.74 M(+21.1%) |
| June 2018 | - | $550.80 K(>+9900.0%) | $3.91 M(-26.0%) |
| Mar 2018 | $5.29 M(+33.3%) | $0.00(-100.0%) | $5.29 M(0.0%) |
| Dec 2017 | - | $2.95 M(+613.0%) | $5.29 M(+83.0%) |
| Sept 2017 | - | $413.60 K(-78.5%) | $2.89 M(-9.9%) |
| June 2017 | - | $1.93 M(+250.0%) | $3.21 M(+47.1%) |
| Mar 2017 | $3.97 M(+82.0%) | - | - |
| Dec 2016 | $2.18 M(+9.2%) | $550.50 K(-24.7%) | $2.18 M(+32.7%) |
| Sept 2016 | - | $730.80 K(+8.6%) | $1.64 M(+80.1%) |
| June 2016 | - | $673.20 K(+198.3%) | $912.10 K(+281.8%) |
| Mar 2016 | - | $225.70 K(+1609.8%) | $238.90 K(+1709.8%) |
| Dec 2015 | $2.00 M(+6258.6%) | - | - |
| Nov 2015 | - | $13.20 K(+266.7%) | $13.20 K(+266.7%) |
| Aug 2015 | $31.40 K(+282.9%) | - | - |
| Nov 2014 | - | $3600.00 | $3600.00 |
| Aug 2014 | $8200.00 | - | - |
FAQ
- What is Biotricity annual cash flow from financing activities?
- What is the all time high annual CFF for Biotricity?
- What is Biotricity annual CFF year-on-year change?
- What is Biotricity quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Biotricity?
- What is Biotricity quarterly CFF year-on-year change?
- What is Biotricity TTM cash flow from financing activities?
- What is the all time high TTM CFF for Biotricity?
- What is Biotricity TTM CFF year-on-year change?
What is Biotricity annual cash flow from financing activities?
The current annual CFF of BTCY is $6.74 M
What is the all time high annual CFF for Biotricity?
Biotricity all-time high annual cash flow from financing activities is $25.17 M
What is Biotricity annual CFF year-on-year change?
Over the past year, BTCY annual cash flow from financing activities has changed by +$4.74 M (+236.82%)
What is Biotricity quarterly cash flow from financing activities?
The current quarterly CFF of BTCY is $471.10 K
What is the all time high quarterly CFF for Biotricity?
Biotricity all-time high quarterly cash flow from financing activities is $14.81 M
What is Biotricity quarterly CFF year-on-year change?
Over the past year, BTCY quarterly cash flow from financing activities has changed by -$2.96 M (-86.26%)
What is Biotricity TTM cash flow from financing activities?
The current TTM CFF of BTCY is $3.32 M
What is the all time high TTM CFF for Biotricity?
Biotricity all-time high TTM cash flow from financing activities is $27.60 M
What is Biotricity TTM CFF year-on-year change?
Over the past year, BTCY TTM cash flow from financing activities has changed by -$4.54 M (-57.76%)